SATURDAY, FEBRUARY 11th, 2017


HALIFAX HEALTH

Ground Floor Auditorium - Entrance #2 (Fountain Bldg.)
303 N. Clyde Blvd.
Daytona Beach, FL 32114
Phone:  386-254-4000
Or
YOU MAY LOG IN AND LISTEN AND VIEW FROM YOUR OWN COMPUTER
 
COMPLIMENTARY SELF-PARKING AND REGISTRATION
Registration: 8:00 AM - 9:00 AM
Opioid Prescribing: 9:00 AM - 12 noon (EST)
Opioid Induced Constipation: 12 noon - 1:00 PM (optional presentation)
 

8:00 AM

REGISTRATION / BREAKFAST

8:55 AM

CME DISCLOSURES AND SPONSOR ACKNOWLEDGEMENT

9:00 AM

OPIOID PRESCRIBING: SAFE PRACTICE, CHANGING LIVES = 3 HOURS SYMPOSIUM

Unit 1:  Assessing Patients for Treatment with ER/LA Opiod Analgesic Therapy

Unit 2:  Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics

Unit 3:  Managing Therapy with ER/LA Opioid Analgesics

Unit 4:  Counseling Patients & Caregivers about Safe Use of ER/LA Opioid Analgesics

10:35 AM

BREAK

 

Unit 5: General Drug Information for ER/LA Opioid Analgesics

Unit 6: Specific Drug Information for ER/LA Opioid Analgesic Products

ASAM Unit: Is My Patient Opioid Addicted? - Diagnosis and Management

Outcomes and Evaluations, Questions

12 NOON

NEW DIRECTIONS IN THE MANAGEMENT OF OPIOID-INDUCED CONSTIPATION IN NON-CANCER PAIN PATIENTS  = 1 HOUR BONUS ACTIVITY

1:00 PM

ADJOURN

This symposium is being offered either LIVE IN PERSON at the Hyatt Hotel or you may LOG IN DIRECTLY FROM YOUR COMPUTER and listen to the presentation and view the ppt at the same time that it is being presented live. Please indicate your choice in the registration form below. If attending via computer, you will be contacted in advance with directions on how to log in on the day of the conference.

ACCREDITATION (3 hrs plus 1 optional bonus hr)

 

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3 AMA PRA Category 1 Credits™.

In addition, the 4th hour will be provided by EXCEL Continuing Education (OIC presentation only):

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

EXCEL Continuing Education designates this live activity for a maximum of one AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants + Nurse Practitioners: AAPA and AANP accept AMA Category 1 Credit from organizations accredited by the ACCME.


EDUCATIONAL OBJECTIVES for OPIOID PRESCRIBING

 
At the conclusion of this conference, you should be able to:
 

Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy as well as possible misuse
   

Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies
   

Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects
   

Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal
   

Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids
   
   

EDUCATIONAL OBJECTIVES for OPIOID-INDUCED CONSTIPATION

 
At the conclusion of this conference, you should be able to:
 

Apply communication strategies to improve the screening of patients for OIC
   

Effectively evaluate patientsí symptoms, changes in bowel pattern, and medical history to guide a diagnosis of OIC
   

Identify risk factors and how they contribute to OIC
   

Discuss management strategies for OIC including lifestyle modifications, laxatives, and targeted prescription therapies
   

Review established and emerging therapeutic agents and how these can improve patient quality of life based on patient symptoms and preferences
   
   

SUPPORTERS

 

RPC Commercial Support Disclosure Statement

Presented by ASAM, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please click on http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies.

This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

The 4th hour on Opioid Induced Constipation is supported through a grant from TAKEDA, SUCAMPO and ASTRA ZENECA PHARMACEUTICALS.



EXCEL CE complies with the Americans Disabilities Act. If any participant is in need of reasonable assistance, please FAX a written request to 305-598-7252 for consideration at least 2 weeks prior to the activity.

 
Click on the link below to download a PDF version of the program.